Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
Read transcripts of webcasts and audiocasts
Read transcripts of webcasts and audiocasts
Disclaimer: This is a machine-generated transcript and may contain inaccuracies.
Welcome to the AAK Q1 2026 report presentation. For the first part of the presentation, participants will be in listen only mode. During the Questions and Answers session, participants are able to ask questions by dialing pound five on their telephone keypad. Today's event will last for 45 minutes. Now, I will hand the conference over to the speakers CEO Johan Westman and CFO Tomas Bergendahl. Please go ahead.
Good morning everyone. Thank you for joining us and thank you for your interest in AAK. As you heard, joining me here today to review our first quarter results is our CFO, Tomas Bergendahl. Please turn to slide number two. Today we will cover quarterly highlights, selected events, and the business and financial update followed by concluding remarks. This presentation is scheduled for 45 minutes in total, including questions and answers at the end. And with that, please turn to page number three regarding forward-looking statements. This presentation includes forward-looking statements that come with risks and uncertainties. These are our views on future events and financial performance, but actual results may differ. With that, please turn to slide four. Quarterly highlights. We delivered a solid start to the year with both organic volume growth and continued strong profitability. As expected, currency translation had a negative impact on reported figures. Operating profit increased by 11% year on year at fixed exchange rates. Growth was more modest at 2%, reflecting the headwind from FX during the quarter. Volumes amounted to 515,000 metric tons, corresponding to a 3% increase year on year. This marks a return to growth following a period of softer demand, supported by improved commercial execution. Profitability remained strong, with operating profit per kilo reaching SEK2.49. This represents a 9% increase at fixed FX rates. The improvement was driven by continued internal optimisation, including productivity and procurement improvements across our oil refining footprint, as well as the ongoing impact from our Fit to Win programme. In addition, we benefited from improved portfolio and price management. Positive operating leverage from higher volumes and supporting market conditions for cocoa butter alternatives. Operating cash flow was strong at SEK1.395 billion. This was supported by earnings as well as a positive effect from working capital. Thomas will elaborate a bit more on the drivers later in this presentation. Return on capital employed was 20.7%, excluding the one-time restructuring cost in Q2 last year. Net debt/EBITDA was at 0.39, reflecting a strong balance sheet and continued financial flexibility. Overall, we are pleased with the start of the year, particularly the return to volume growth and continued strong profitability. At the same time, we are not satisfied and we remain focused on further improving our performance. Our priorities remain clear. Drive volumes, strengthen profitability, and maintain discipline in execution. And with that, let's turn to the next slide. Some comments on selected events. Starting with the annual report for 2025 published earlier this month. This is our first fully integrated report combining financial and sustainability disclosures in line with the new CSRD regulation. This is now a requirement, but also an important step in increasing transparency in how we report our sustainability impact. A key element is our first double materiality assessment, which forms the foundation for how we identify and report our most relevant impacts, risks and opportunities. The sustainability statement has also been subject to limited assurance by our external auditor. During the quarter, we also participated in the World Economic Forum in Davos. I represented AAK in discussions with industry leaders, policymakers and experts on topics central to our strategy, particularly the role of food systems in supporting better health outcomes. Building on this, we saw an increased focus on non-communicable diseases where AAK was invited to contribute a broader system-level perspective in relation to this. This aligns well with our role in complex value chains and our focus on scalable, plant-based solutions. And importantly, Davos provides a platform to position AAK at the center of key global discussions and strengthen relationships that support our long-term strategic priorities. Turning to sustainability performance, we were awarded a silver medal in the 2026 EcoVadis assessment. We achieved a score of 74 out of 100, placing us in the top 12% of companies in our category. The rating reflects continued strength in areas such as environmental reporting and supply chain due diligence. Finally, an update on our new food service facility in Staffanstorp, Sweden. Construction is progressing well and according to plan, both in terms of timeline and budget. The facility is expected to be fully operational by the end of this year, with production ramping up through 2027 replacing the current Dalby site. Once completed, the site will strengthen our food service platform through increased capacity, improved efficiency, and more scalable operations. Overall, these developments reflect continued progress across our strategic priorities, from transparency and sustainability to external engagement and capacity expansion. Please turn to the next slide for a review of performance. Let's start with the Food Ingredients business area. Volumes in Food Ingredients increased by 5% year on year. Growth was relatively broad-based across segments and regions. In bakery, we saw a broad based growth across all regions led by Asia, the Middle East and Africa. In dairy, performance was mixed with overall volumes declining. Asia, the Middle East and Africa grew, while the Americas and Europe declined; specifically, nutrition grew slightly year on year, driven by Europe, though other regions were softer, and foodservice declined slightly compared to the first quarter last year. Operating profit per kilo amounted to 2.42, down 7% year on year. In the reported numbers. This includes a currency headwind of 0.21 per kilo at fixed exchange rates. Operating profit per kilo increased by 2%. Operating profit decreased by 2% to 752 million. This includes a negative currency impact of 66 million at fixed exchange rates. Operating profit increased by 6%. Next slide please, over to Chocolate and Confectionary Fats. Volumes in chocolate and confectionery fats declined by 1% year on year. Performance was mixed across regions. The Americas and Europe declined, while Asia, the Middle East and Africa grew. From a product mix perspective, the portfolio of cocoa butter alternatives developed positively and grew in the quarter, including KBS. That was flat year on year. This, together with higher volumes in spread, was offset by lower volumes in filling fats and non-specialty single oil solutions. Operating profit per kilo increased to 4.23. This includes a negative currency impact of 0.43 per kilo. At fixed exchange rates. Operating profit per kilo increased by 14%. Operating profit increased by 2% to SEK 532 million. Currency had a negative impact of SEK 54 million. So at fixed exchange rates, operating profit increased by 12% in the quarter. Over to the next slide and highlights for Technical Products and Feed, where volumes grew by 1% year on year. Performance was mixed across segments where technical products delivered growth in the quarter, while feed declined slightly. Operating profit per kilo increased by 3% to 6.7. Operating profit increased by 4% to 54 million. With that, we have now covered the three business areas. I will hand it over to Thomas to review the first quarter financial results, as well as a closer look at our current CapEx priorities. Over to you, Thomas. Thank you, Johan. Good morning everyone. Please turn to slide nine. Operating cash flow amounted to a positive 1.4 billion SEK in the quarter. Working capital decreased, contributing to the positive cash flow. This was driven by a reduction in inventory and an increase in accounts payable, while accounts receivable increased, driven by volume growth and seasonality, which then negatively impacted the cash flow. The decrease of the inventory in the quarter of almost 500 million SEK was driven by lower inventory levels, partially offset by an increase in price of raw materials. CapEx amounted to 290 million SEK in Q1, comprised mainly of investments related to maintenance, productivity improvements, capacity increases, and debottlenecking. The CapEx spend for the full year of 2026 is expected to be slightly higher compared to 2025 at roughly 1.5 billion SEK, and in line with the indications given in connection with the Q4 report. And I will come back to our CapEx spend later on in the presentation. Free cash flow amounted to a positive 1.1 billion SEK for the quarter. Turning to slide ten, return on capital employed for the quarter remained strong at 20.7% and on par with last quarter. Adjusted for the one-time restructuring cost of 250 million SEK recognized in Q2 2025. Year over year, the return on capital employed is slightly down from 22%, mainly prompted by the increase in working capital driven by raw material prices. Turn to slide 11, please. The net debt to EBITDA ratio came down from 0.6 in the previous quarter to 0.39 in Q1, close to the recent low of 2.29 in Q4 2024. The ratio is expected to increase in Q2 2026, all else equal, driven by a dividend and the initiation of the share buyback program, provided that these are approved by the AGM. Turning to slide 12. Let me briefly touch on capital expenditure. As previously communicated and mentioned in this presentation, our investment level for 2026 is expected to be somewhat higher than in recent years, at around 1.5 billion. Starting with project governance, on the left-hand side, our investments follow a structured and disciplined process. Each year, we build a three-year rolling pipeline based on bottom-up input from our sites and regions. This is then prioritized and aligned through the annual strategic planning process, in combination with the target setting of the coming year for 2026. This translated into an initial pipeline of about 2.5 billion. Then we have prioritized this list down to approximately 1.5 billion. The pipeline is split between maintenance, optimization and growth projects. The first category, roughly 600 million SEK, or 40% of the spend, ensures operational stability, efficiency and sustainability across our existing footprint. While growth projects are focused on capability and capacity development, strengthening long-term competitiveness and enabling future volume growth. Moving to our current investments making up the 2026 CapEx. These are focused on three main areas. Firstly, supply chain resilience. Here we're evaluating a potential investment in the key value chain in West Africa, including crushing in Ghana and processing the already announced joint venture. Progressing the already announced joint venture with KLK in Malaysia for specialty palm fractions, both aimed at reducing volatility by supporting a more secure access to and quality of key raw materials. Second, capacity. This includes investments in food service, such as the new facility in Staffanstorp, Sweden that Johan mentioned before, and a hot fill capability in Runcorn facility in the UK. Also, foodservice-enabling impact pasteurization for cleaner label products without added preservatives, thereby enabling entry into adjacent categories. It also includes continued expansion in Karlshamn, Sweden, all aimed at supporting future volume growth and a more flexible and scalable production footprint. Third, portfolio enhancement and technology. Here, we're increasingly investing in innovation, often in collaboration with external partners, to meet future demand for healthier and more nutritious food. Improved functionality such as taste and texture, more sustainable solutions, and increased supply chain resilience and versatility. And this is closely linked to our Better Futures innovation pillar that we have shown and discussed before. Key areas include precision fermentation, power-to-X technologies, and enzymatic processes, where we continue to build capabilities through both near-term and long-term projects. We're also exploring new natural inputs for non-food applications from non-food, non-fossil sources, although this remains at an early stage. In addition, we're investing in a pharma facility in India focused on non-active delivery systems, strengthening our position in higher value added specialty ingredients and expanding into adjacent growth segments. While these investments are smaller in scale today, there are important building blocks for future growth and long-term competitiveness. Finally, on the right hand side, from a capital markets perspective, these investments support de-risking of supply chains, capability and capacity for volume growth as well as stronger sustainability positioning. Together, this strengthens our ability to deliver long-term margin resilience and earnings growth in line with our 2030 aspiration. And with that, I will hand it back to Johan for a summary and concluding remarks before we go for questions.
Thank you, Thomas, and please turn to the next page. To conclude, while the first quarter showed early signs of a return to volume growth, market conditions remain somewhat cautious. Near-term visibility is still limited, and we therefore remain focused on the areas within our control. This means continued emphasis on disciplined commercial execution, operational efficiency, and maintaining a strong cost and productivity focus. Looking further ahead, we remain prudently optimistic about our long-term potential. We are committed to progressing toward our 2030 aspiration with clear priorities across growth, profitability and impact. We will continue to invest in our capabilities, strengthen our portfolio, and allocate capital in a disciplined way. All of this supports our ambition to deliver sustainable growth and long term shareholder value. With that, I will hand it back to the operator and open up for questions.
If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Johann Fred from SEB. Please go ahead.
Good morning. I wanted to thank you for taking my questions. I will limit myself to two, if I may. The first one on the volume development in Food Ingredients. So, as you state, volume growth was driven by non-specialty solutions and bakery. How does this align with your portfolio optimization strategy? Is this a deliberate mix shift to fill capacity, or is it more of a symptom of softness in higher value ends of the market, or something else? Maybe.
Thank you. If we start with a volume question linked to Food Ingredients and bakery, to drive growth through a market situation that we describe as a bit cautious and the dynamics that we see around us in the world, we have been focusing on and have communicated our efforts and actions linked to commercial execution and return to sales growth, which includes a better and more educated decision process where we look at capacity in different factories to look at whether we want to win the volume or not, if it has positive leverage. So to some extent, this is a result of filling factories. Yes, but filling factories in a disciplined manner, protecting margin as far as we can. And I think that's what we see here. Maybe a few more tons of non-specialty here and there, but still with positive leverage enough to be able to, as we report in fixed currencies, increase our earnings and an even margin. So, all in all, we are positive about the way we have executed that. Anything to add to that picture?
No, I think it's just important to emphasize that the margin, as you can see, is flat versus last year, despite that.
Or even slightly.
Increased, and increasing at fixed FX. Right. So that's the the one to keep an eye on.
Yeah.
Yeah. And that was actually my second question. I would have assumed that you had benefited more from operational leverage. As you stated, the volume growth was 5% in Food Ingredients. But the EBIT per kilo at fixed FX was only up 2%. So is the culprit here simply that growth is coming from wrong parts of the portfolio in Q1? Or is it something more structural?
No, I wouldn't say there's something wrong in that. But I think, as I explained before, our target is to always go for earnings growth. So our number one target is growing our earnings operating profit. And that can come through margin expansion or volume or ideally both. And if we look at Food Ingredients in particular, volume growth is up 5% and operating profit is up 6%. One could argue. Wouldn't you have higher leverage if the mix was the same? That would be correct, yes. But in order to fight for these volumes, we also need to do so where volumes exist. So I think we have deliberately tried to fill our factories. And that includes sometimes taking in business that is of lower value added, while at the same time focusing on growing the value-added part of the portfolio. So I would say that these are deliberate actions. And not to say that we are growing in the wrong segments, but rather we are using our capacity in our factories and we're loading them in a disciplined way.
And when you look at this, you also have to look at the whole company and how margins develop, because as we mentioned before, we don't have Food Ingredients factories there. Also in combination with what we do on CCF and so forth. Right. And if you look at that and you see that we have a 3% volume increase, we also have a 9% margin improvement at fixed rates. And you can argue back and forth on fixed rates. But if we look at the local performance in local currency, those are the margin improvements that we see. So that's the underlying of the 3% volume increase. And if we also look at the comp within Food Ingredients, it was fairly high last year, 2.59, and versus Q4, we were up 3% in EBIT per kilo in Food Ingredients as well. So I would say you do see the leverage in the numbers.
And that's an important comment that the factory loading is across both Food Ingredients and Chocolate & Confectionery Fats, not just Food Ingredients.
Got it. Got it. Very clear. Thank you for that. Thank you. Thank you. thank you.
The next question comes from Benjamin Wahlstedt from ABG Sundal Collier. Please go ahead.
Good morning. Turning the focus to CCF, you highlight favorable market conditions for cocoa butter alternatives as a tailwind. You also note that cocoa butter prices have softened from their peak; at what cocoa butter price level does the economic case for substitution weaken materially for your customers, do you think? And how exposed is your EBIT per kilo or CCF margin to a further normalization in cocoa prices? I know we've spoken about this at length previously. Just trying to get an update here.
Absolutely. Let's continue on that. I think, first of all, in an overall perspective, we have a view that it's rather more positive than negative that you see a normalization, or coming back to normal, on the cocoa prices. Because what it did lead to was heavy inflation in retail, making chocolate and confectionery very expensive for consumers and even leading consumer product companies to do a bit of shrinkflation, which has a negative impact on volume. So, all in all, I would argue that this is positive, right? What we mean by a positive contribution is that we have seen the elevated levels. They are still comparatively high. And that gives you a further reason to look for cost-efficient alternatives to cocoa butter, where we come into play. Now, the stickiness and the stability or resilience in our earnings in CCF is also linked to the fact that our cocoa butter replacers do not just replace. It also brings functionality which improves our customers' products. And that's where the stickiness is, because you don't want to reformulate quarterly just because of the movement of the raw material. And back to your comment there on where is it? Where would it be concerning? I think, to put it simply, it would only be really concerning if you had a structural, long-term price of cocoa butter that were below the input cost of the alternatives, because then you would argue that cocoa butter would be more cost-efficient than the alternatives. Alternatives. We are not there today and we haven't been there. There's been maybe one point in time in history where that was the case, but that was for a short period of time. So we're not concerned with this. Theoretically, that could be a risk. But I do believe that if you would see structural volume decline in the alternatives, you would also see that input costs would fall as a result of lower volume. And then you would have a correction again. So I think this is quite resilient, although you can never make promises on the future.
And I would also add to that, as you know, when you look at the cocoa butter prices, they peaked about 12 months ago and have been dropping since. Right. So there is a track record now also of lower prices and of maintaining our margins and so forth. The margin improvement in CCF, I think it was 3% including effects and 12% at fixed FX, is mainly driven by mix. So, even if the volume was flat, you have higher volumes of high-margin products versus low-margin products for CCF in the quarter, right? So that's driving the continued improvement.
Perfect. Thank you very much. I was wondering as well if you could elaborate on the volume decline in CCF. Perhaps specifically, you make the comment that non-specialized volumes declined. Could you elaborate or perhaps say what share of the volume decline for the segment as a whole is attributed to non-specialized volumes and perhaps just say, if that's a deliberate decision or how we should view that. Thank you.
Yeah. If we speak about the decline, let's keep in mind it's 1%. So it's kind of minor, flattish. And we believe that our volume in the quarter is, if anything, slightly better than the market. So in that context, I think it's more like in line with market. So I wouldn't call it any drama around volume up or down. Within the mix, though, if we talk about that, it's positive to see that our cocoa butter alternatives, which include CBRs, CBS, and cocoa butter equivalents, performed well, also within spreads, right? So these are high-value-added solutions that we bring, and we deliberately focus on them. But just as I mentioned a bit on Food Ingredients, we also try to load factories with decent volumes. So, a lot of what we do is under the umbrella of commercial execution and discipline. A lot of what we do is with intent and deliberate; however, it is very difficult to find an optimal balance between non-specialty and specialty in every given moment. We need to take contract by contract. But the long-term focus of the company is to invest more into the higher value-added segments versus the lower value-added segments. So I wouldn't put too much emphasis on the mix, since we are speaking of small numbers in terms of decline.
Perfect. Thank you very much. I'll get back in the queue.
Thank you.
The next question comes from Victor Hansen from DNB Carnegie. Please go ahead.
Hi. Johan and Thomas Victor here. A couple of questions from my side. I'll begin with food ingredients volumes. We've spoken a bit about it here today, but it consists of many different categories. What is your qualified estimate of overall market volumes in Q1? Within Food Ingredients.
It is, as you say, an area where it's more difficult to actually say what it is. I would say low single digit, if anything. But we have better data indicating a decline, or perhaps stagnation. Yeah, it's a soft environment still.
Okay. Uh, thank you. And then.
Just to add to that, what we do see, and that's new this quarter compared to the last, I'd say 4 or 5 quarters, is that we see bakery growing again (which is really good to see), and dairy that has shown strength over the last 4 or 5 quarters is softening a bit, but that's because of high or low milk prices in the regions where we are present with our substitutes. Right. So it's a bit dependent on that. So, really nice to see bakery stepping up again.
Perfect. Thank you. On CCF, we received some positive volume outlooks from various chocolate manufacturers here quite recently. Is it reasonable to expect volume growth for AAK starting possibly already from Q2, or do lead times point to a later point in time for you?
Obviously, lead times play a role here since, as I always repeat, that internally and externally. We supply to production of products. So there are lead times in our supply chain for sure. And then with regards to an outlook, we have also seen those comments from companies within our industry. We do not make a formal guidance. I think it's worth keeping in mind that we have some dynamics in the world that create uncertainty. But should these forecasts from other companies materialize, it would be positive for the absolute volume growth of CCF.
Okay, perfect. Thank you. I have a final question probably aimed towards Tomas. It's on the cash flow. So cash flow was strong, and you had a medium-sized working capital release. I'm wondering, is this just price driven, or are you starting to trim the inventory days? And a follow up to that question. Generally the inventory days have been increasing a lot for quite a few number of years now. And I know many investors are asking about this. So what are your thoughts on inventory days going forward? Will you prioritize working capital more going forward?
Thank you. I would say we have a big, big focus on working capital and have had for some time, though that wasn't always the case. Maybe if you go back a number of years for AAK, but last couple of years we've had active projects in place to review our inventory levels to see how we can do things more efficiently. For Q1, there are two impacts on the positive side. One is that our inventory levels are at a more efficient level. So we have decreased our inventory despite the 3% increase in volumes. There's also seasonality because two main crops, rapeseed and shea kernels are only sourced in sort of late Q2, Q3, early Q4, and in Q1, we sort of used the inventory without replenishing it because it's a seasonal acquisition of that inventory. So those two effects come in. But we do also see, as you can see in the presentation, there are price increases that are driving the inventory values the other way. And if you look at the long term, as you also reflect on, I would say that yes, it has been a bit of a tough ride from an inventory perspective for us, but it goes back again to what was mentioned earlier in the call. We are very susceptible to the price levels of raw materials. So when price levels increase and if you compare it to before the pandemic, they're up 2.7 to 2.8 times of where we were five years ago. I would say that we make sure that we can increase our prices to maintain our margins and increase them. And you've seen that over the past five years. We've done that really well. What is very difficult is to offset the raw material price increases in our inventory values. So if we replace an inventory item, if you will, for production, last time we bought it, it cost $100. Now it costs 150. That will increase inventory levels because we also sit on working capital between when we buy and when we receive funds from our customers in terms of paid receivables. So that is an effect that's very difficult to manage. But looking at the overall, we also see that when price drops, as it did mid to late Q3 2022, you see cash flow coming in in a big way. We had very positive cash flow coming in there. So that's one of the sort of complexities that we live with.
Okay. Thank you very much. That's all for me.
The next question comes from Matthew Abraham from Berenberg. Please go ahead.
Good morning all. Thanks for taking my questions. Our first one just is another one in reference to Food Ingredients volume. You've mentioned that the bakery has gone back to volume growth and dairy now in volume decline. Just wondering if there's a mixed effect there. And the impact from that mixed effect is EBIT per kilo. I appreciate you've spoken a bit about capacity utilization, but just wondering if the change in that volume growth dynamic is impacting that EBIT per kilo outcome.
Between bakery and dairy. That is not a big explaining factor. I would rather say that the total mix that we talked about before, from which we get the volume and the leverage, you could say, but at the same time, sometimes you have to give a bit on price to win business, and that may mean a slight price reduction. The total mix is what's important. And that is a growth of absolute profit by 6% in fixed currencies. The one segment with higher EBIT per kilo is Special Nutrition, which has a slight positive volume increase, but still, low numbers compared to the big volume drivers in dairy and bakery.
Okay, I understood. A follow-up question just in reference to the CapEx color that you provided, talking to increasing capacity. Just wondering how we should think about the evolution of margin given the capacity that you're adding to the group.
We are very much focused on that in our total optimization effort that we have commented and written about over some years that has included a much tougher way to get new CapEx on the table. So, I wouldn't see that CapEx from AAK would lead to margins going down. We rather do that with a bit more lag; when we really need it or to optimize production, that's when we add it. So, our ambition is to run a tight ship and to focus on margin expansion while adding capacity where needed.
And capacity additions are very local where we see that the market demands it. There is potential in the market, right. So we are selective, I would say. Capability is a little bit different where we can see that we can go into a market where we are already with new products or versions of new products and so forth. But on capacity, we are very selective.
Okay. That's helpful. Just one more. If I may, the cocoa butter alternatives portfolio, can you just talk to the scale of the pipeline for that element of CCF and whether or not it's remained in growth despite the lower cocoa price backdrop?
Yeah. We cannot comment on the pipeline or disclose that, but speaking about how we operate in CCF... CCF is one of the strongholds of AAK. Our center of excellence is well visited by our customers, and we are a go-to partner for them regarding solutions to chocolate and confectionery products that could be for cost efficiency, shelf life, improved texture, and taste. . So our pipeline is healthy in that we have a continued focus and drive regarding cocoa butter prices. We have seen, as Thomas mentioned, cocoa price was on the rise and has now come down, and we still see a stable development for AAK in that context. And over a long period of time, you have typically seen cocoa butter prices being higher than the closest alternative, which is our cocoa butter equivalents. Obviously, in a very short time frame, you could see that input cost could be higher for the alternative versus the cocoa butter price. But over time, it has been more normal to see that there is a healthy delta between the two. So I rather see a positive development with cocoa prices coming down, because it stops the structural inflation at the shelf in retail that we have seen with the sharp rises. So if anything, it should be positive for inflation going forward.
Thanks. I'll pass it on. Thank you. Cheers.
The next question comes from Eric Sandstedt from Kepler Cheuvreux. Please go ahead.
Hi. Thanks, Eric. With Kepler Cheuvreux, I have a few questions on pricing. Are you seeing any pushback from customers on pricing given the challenging market environment? And I'm thinking about CCF in particular.
Thank you. I think that is more a given than anything else. We live in a global environment with many big customers, global players, professional procurement organizations. There is always an element of negotiation and price. And obviously our customers have seen inflationary items hitting them. And with that comes the focus on costs. But that's the name of the game. We see that all the time. That's also where companies with a professional, long-term, global perspective can also support that some of our solutions are, in fact, a more cost-efficient solution than the alternative. There's always going to be a question on price. I don't see that changing a lot at the moment. It's just a standard rather than anything else.
Makes sense. Thanks. And then in terms of group function costs, they were quite low this quarter. Is this driven by the efficiency program or were there other sort of more temporary factors at play here. And what is a normalized level going forward. Group function costs.
Uh, yeah. There are some, from quarter to quarter, sometimes some one-time effects. But I would say that, as you can see if you look back at the history. But I would say that one of the main drivers is, of course, the cost reduction program that we're running as well since April of last year. But each quarter is a bit different in terms of group function. And I would say that maybe looking at around 80 million or so per quarter would be a rough average, I think, to stick to, but it may vary from quarter to quarter.
Perfect. Thanks. And then just finally follow up on the previous discussions about spare capacity. Can you say how much spare capacity you actually have now and how it compares to historical and normal levels?
It's changing all the time, as we've said before. It depends on what type of product we run through each factory. So it's a moving target, if you will. But we've indicated before, and we can do so again now, I think we are at the same level that we've seen before, around 15%, but it varies between the different units. And it's very local in how it works. Right. But that's where we are more or less, I would say in line with the previous indications.
So maybe, adding to it after a few years with volume decline, including efficiency and optimization program, internally, we've freed up capacity, if you will. So around that average, 15% free capacity would be something to work with. Yeah.
Thanks. Yes.
Yeah. If all else remains equal as it is now, yes, Q1 will be the biggest quarter in 2026. It will continue to be negative throughout the year, but it will be on a declining level from Q1, if you will. And we saw that in Q1 as well. Month to month, January made up about half of the FX effect for Q1. So yes, we will see a decline, but it will still be negative throughout the year. I'm not projecting it, but if you just take the calculation where we are now with the current rates and disregard that they will probably move going forward, you will probably be at around 280 to 300 million for the full year. But again, things change then, right? But that's where we are if you make the calculations today.
Yeah. Perfect. Thanks.
The next question comes from Priya Patel from UBS. Please go ahead.
Hi. Thanks for taking my questions. I've got two. So firstly just on Food Ingredients again. I was wondering how much bakery grew within this and how this compares to the end market. And then just on non-specialty oils, which is also a driver of the volume growth, but drove the weaker mix that you saw in Food Ingredients. I know you don't guide, but can you help me understand how you expect the mix to develop in a more challenging end market? And what could drive the demand for some of the more specialty products? Thanks.
The execution or the business model in AAK is that everywhere where we operate, quite a lot of what we sell and deliver is, is local, right. So we have global customer accounts. However, we deliver locally to local production, be that in China, India or the US or Brazil. So what we are focusing on is always driving our mix and our engagement with our customers where we make a difference. And that is with more advanced products and ingredients. At the same time. We run big refineries, so we also need to load our factories and make sure we utilize those assets. And it is in that mix. We always try to focus on achieving an absolute EBIT growth. So, what we should expect or what we are driving towards in our strategy is a higher degree of specialized solutions overall. But while doing that, we will always also target an absolute EBIT growth. So, so that's as far as we guide, if you will.
This will be our last question for today. The next question comes from Matthew Yates from Bank of America. Please go ahead.
Hey good morning everyone. Just a couple of questions to finish off. Apologies if I should know this, but your long term target of three SEK per kilo, when that was given, was it said that that was at constant currency. I'm just wondering that you've probably accumulated a 30-40 cent headwind since that was given. Does that mean the target needs to be rebased at some point to reflect the currency environment? Or do you think there's other levers you can pull to offset that headwind? The second question really for Thomas around the CapEx strategy, and I appreciate what you're saying about discipline. And I guess the reality is 1.5 billion is a record amount of spend for the company. Nevertheless, the balance sheet is incredibly strong. So when you're looking at project reviews and scrutiny around that, is it that the organization is presenting you with returns that aren't that attractive? Or do you simply not have the human resource capability to manage more projects? At this point, I'm just wondering whether you are leaving some growth on the table because you're clearly not capital constrained. Thank you.
Thank you. Regarding the first question, the three SEK per kilo target was not communicated or decided in a fixed FX environment. But at the same time, in a year-on-year comparison, given that we report in Swedish krona, I think it's very relevant because what we do is obviously, as I mentioned before, we operate and sell locally and we earn our money in dollars and euros and so forth. So I think it's very relevant to look at that. But we remain at our target three SEK per kilo. It was not given with an assumption on currency. And from where we are today at roughly 2.5, with years to go, we see potential and are absolutely committed to deliver on that. And that's where we are, right? So I wouldn't bring FX into that conversation. It's more relevant in a year-on-year comparison. And then Thomas, maybe a bit on.
So thank you for the CapEx question. Good one. We estimate about 1.5 billion, as we mentioned, 40% of that is related to maintenance or upkeep activities. 60% is the remainder; I'd say most of that for 2026, the majority would be towards capability. When we look at your question and what we can actually do? How much can we manage? I think there are possibilities to, from a resource point of view, to do a bit more, especially if it's in different locations; if a lot of it ends up in one location, then it becomes more difficult, as is easily understood. Right, the problem, I think, with having to prioritize a bit is that when we look at some of these cases, they. The softest input into the cases is the volume assumptions. And those are the ones that we struggle the most with. So a lot of the capability we like, sometimes it's even connected to a particular customer, launch and so forth. So that looks good. When we look at pure capacity increases in markets that are sort of mature, and that have shown limited growth over the past three, four years. We are very stringent. And it's probably the other way around that the organization is pitching a bit more optimistic business cases than maybe what we can see. So it's through a joint, very constructive discussion that we make these choices. It's not for Johan and me to sit there and say yes or no, but we challenge the cases and we have a good, constructive process with several people involved throughout to make those decisions. So I would say it's much more about capability, and more of that capacity in mature markets. We're much more careful. And if it ends up in one plant, all of it, then resources are constrained. Otherwise, I would say that's something that we can manage, but we want to see good returns on these things, right? Even if we have a good balance sheet, the returns are extremely important to us to continue our return on capital employed at the levels that we are today.
Thank you both.
Thank you.
I hand the conference back to the speakers for any closing comments.
Thank you so much. Once again, thank you for the interest in AAK and for your questions. We have started the year well with organic volume growth, strong cash flow, and in fixed currency, a strong earnings growth and a good margin.



















